Logo

American Heart Association

  40
  0


Final ID:

Pragmatic and Registry-Embedded Trials

  • Spertus, John  ( Saint Lukes Mid America Heart Inst , Kansas City , Missouri , United States )
  • Fonarow, Gregg  ( UCLA MEDICAL CENTER , Los Angeles , California , United States )
  • Author Disclosures:
    John Spertus: DO have relevant financial relationships ; Consultant:BioHaven, Janssen, Bristol Meyers Squibb, Terumo, Cytokinetics, BridgeBio, VentricHealth, and Imbria:Active (exists now) ; Executive Role:Blue Cross Blue Shield of Kansas City:Active (exists now) ; Royalties/Patent Beneficiary:SAQ, KCCQ, PAQ:Active (exists now) | Gregg Fonarow: DO have relevant financial relationships ; Consultant:AstraZeneca:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

More abstracts on this topic:
More abstracts from these authors:
Engaging with patients, caregivers and research stakeholders

Masterson Creber Ruth, Spertus John

Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor Among Patients Hospitalized with Heart Failure and Preserved Ejection Fraction in the United States

Abdel Jawad Mohammad, Spertus John, Greene Stephen, Ikeaba Uchechukwu, Chiswell Karen, Fonarow Gregg, Chan Paul

You have to be authorized to contact abstract author. Please, Login
Not Available